Compare AGCO Corporation (AGCO) vs Cronos Group Inc (CRON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AGCO Corporation vs Cronos Group Inc — how do they compare? AGCO Corporation trades at $102.25 (market cap $7.10B), while Cronos Group Inc trades at $3.08 (market cap $1.14B). The key difference: AGCO Corporation is far larger — about 6.2× Cronos Group Inc's market cap, and AGCO Corporation pays a 1.18% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| AGCO | CRON | |
|---|---|---|
Market Cap | $7.10B | $1.14B |
Sector | Industrials | Health |
52-Week High | $140.49 | $3.27 |
52-Week Low | $100.14 | $2.30 |
Enterprise Value | $9.37B | $341.13M |
Dividend Yield | 1.18% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AGCO Corporation
Agco is a global manufacturer of agricultural equipment. The company has five principal brands: Fendt, Massey Ferguson, Challenger, Valtra, and GSI. Unlike its competitors, Agco's product line extends beyond self-propelled equipment and implements by offering grain handling systems and livestock management solutions. Its products are available through a global dealer network, which includes over 3,200 dealer and distribution locations. Additionally, Agco offers both retail and wholesale financing to customers through its joint venture with Rabobank, a European food and agriculture focused bank.
Read more on AGCO →About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →
